局部用德尔戈西提尼布用于治疗慢性手湿疹
Asaad Abdelhalim1, Orhan Yilmaz2, Mohamed Elshaikh Berair3
1Allergy and Clinical Immunology Department, King Khalid Hospital, Hafar Al Batin, Saudi Arabia.
The Journal of dermatological treatment
|March 17, 2025
概括
局部使用的德尔戈替尼 (delgocitinib) 通过减少和疼痛等症状,有效治疗慢性手湿疹 (CHE). 这种泛JAK抑制剂具有良好的安全性,为中度至重度CHE患者提供了新的治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性手湿疹 (CHE) 显著影响患者的生活质量.
- 涉及细胞因子的炎症途径是CHE病变发生的关键.
- 局部用德尔戈替尼 (delgocitinib) 作为泛-JAK抑制剂向这些途径.
研究的目的:
- 审查CHE的局部德尔戈西提尼布的临床效用和安全性.
- 综合目前关于德尔戈提尼布疗效和耐受性的证据.
- 定位delgocitinib作为中度至重度CHE的治疗选择.
主要方法:
- 在PubMed,Medline和ClinicalTrials.gov的文献搜索,截至2025年1月21日.
- 包括评估delgocitinib治疗慢性手湿疹的研究.
- 叙事综述综合临床试验数据.
主要成果:
- 德尔戈西提尼布奶油显著改善了湿疹严重程度,疼痛和.
- 与载体治疗相比,患者报告的结果得到了增强.
- 局部用德尔戈替尼布表现出良好的安全性,主要是轻微的不良事件.
结论:
- 局部用德尔戈西提尼布是适度至重度CHE的有价值的治疗选择.
- 该药物显示出良好的安全性,治疗中断时间最小.
- 需要对其他治疗方法进行进一步的比较研究,例如口服JAK抑制剂.
相关概念视频
Hand hygiene
3.1K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
123
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
123
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83


